StockData
Elanco Animal Health Inc logo

Elanco Animal Health Inc (ELAN) stock

ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30146% above fair value
$25.74−0.55 (-2.09%)

Close on Nov 20, 2026Market cap $12.86BP/E –Yield –

Elanco Animal Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Elanco Animal Health's free cash flow for the twelve months ending Jun 30, 2026 was $379.00M, up 5.0% year over year. For fiscal 2025 it was $284.00M, down 27.9% from the year before. The highest annual figure on record is $394.00M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$284.00M-27.9%
FY2024Dec 31, 2024$394.00M+200.8%
FY2023Dec 31, 2023$131.00M-53.4%
FY2022Dec 31, 2022$281.00M-13.3%
FY2021Dec 31, 2021$324.00M–
FY2020Dec 31, 2020-$176.00M-309.5%
FY2019Dec 31, 2019$84.00M-76.2%
FY2018Dec 31, 2018$352.80M+369.1%
FY2017Dec 31, 2017$75.20M+64.9%
FY2016Dec 31, 2016$45.60M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$244.00M+35.6%
Q1 FY2026Mar 31, 2026-$38.00M–
Q4 FY2025Dec 31, 2025$46.00M-64.6%
Q3 FY2025Sep 30, 2025$127.00M+5.8%
Q2 FY2025Jun 30, 2025$180.00M+8.4%
Q1 FY2025Mar 31, 2025-$69.00M–
Q4 FY2024Dec 31, 2024$130.00M+12.1%
Q3 FY2024Sep 30, 2024$120.00M-27.3%
Q2 FY2024Jun 30, 2024$166.00M+773.7%
Q1 FY2024Mar 31, 2024-$22.00M–
Q4 FY2023Dec 31, 2023$116.00M–
Q3 FY2023Sep 30, 2023$165.00M+1.2%
Q2 FY2023Jun 30, 2023$19.00M-93.4%
Q1 FY2023Mar 31, 2023-$169.00M–
Q4 FY2022Dec 31, 2022-$87.00M-170.2%
Q3 FY2022Sep 30, 2022$163.00M+154.7%
Q2 FY2022Jun 30, 2022$286.00M+116.7%
Q1 FY2022Mar 31, 2022-$81.00M-2125.0%
Q4 FY2021Dec 31, 2021$124.00M–
Q3 FY2021Sep 30, 2021$64.00M–
Q2 FY2021Jun 30, 2021$132.00M+266.7%
Q1 FY2021Mar 31, 2021$4.00M-90.4%
Q4 FY2020Dec 31, 2020-$212.00M-906.1%
Q1 FY2020Mar 31, 2020-$9.00M–
Q4 FY2019Dec 31, 2019$36.00M-54.6%
Q3 FY2019Sep 30, 2019$41.60M-71.5%
Q2 FY2019Jun 30, 2019$26.30M-76.7%
Q1 FY2019Mar 31, 2019-$19.90M-239.2%
Q4 FY2018Dec 31, 2018$79.30M–
Q3 FY2018Sep 30, 2018$146.10M–
Q2 FY2018Jun 30, 2018$113.10M–
Q1 FY2018Mar 31, 2018$14.30M–
Q4 FY2017Dec 31, 2017-$60.20M–

More Elanco Animal Health figures

See a number that looks wrong?